Evidence map›Paper›PMID 34478336›Full record

ArticleThe British journal of radiology2021

Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study.

Feihong Yu, Jing Hang, Jing Deng, Bin Yang, Jianxiang Wang, Xinhua Ye, Yun Liu

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The British journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Feature Extraction of Ultrasound Radiofrequency Data for the Classification of the Peripheral Zone of Human Prostate.Proceedings of SPIE--the International Society for Optical Engineering · 2024
    Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Feihong YuDepartment of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jing HangDepartment of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jing DengDepartment of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Bin YangDepartment of Ultrasound, Jinling Clinical Medical College, Nanjing Medical University, Nanjing, China.
Jianxiang WangDepartment of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xinhua YeDepartment of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yun LiuDepartment of Information, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the predictive value of radiomics nomogram using pretreatment ultrasound for disease-free survival (DFS) after resection of triple negative breast cancer (TNBC). METHODS AND MATERIALS: A total of 486 TNBC patients from 3 different institutions were consecutively recruited for this study. They were categorized into the primary cohort (

resultsThe patients with higher Rad-score had a worse prognostic outcome than those with lower Rad-score in primary cohort and two validation cohorts (All

conclusionsThe ultrasound-based radiomics signature was a promising biomarker for risk stratification for TNBC patients. Furthermore, the proposed radiomics modal integrating the optimal radiomics features and clinical data provided individual relapse risk accurately. ADVANCES IN KNOWLEDGE: The radiomics model integrating radiomic signature and independent clinicopathological variables could improve individual prognostic evaluation and facilitate therapeutic decision-making, which demonstrated the incremental value of the radiomics signature for prognostic prediction in TNBC.

Indexed as

AgedAlgorithmsDisease-Free SurvivalFemaleHumansLymphatic MetastasisMiddle AgedNomogramsPredictive Value of TestsPrognosisRisk AssessmentTriple Negative Breast NeoplasmsUltrasonography, Mammary

Identifiers

PMID34478336
PMCPMC9328043
OpenAlexW3197479046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.